William Plovanic analyst CANACCORD

Currently out of the existing stock ratings of William Plovanic, 170 are a BUY (87.63%), 24 are a HOLD (12.37%).

William Plovanic

Work Performance Price Targets & Ratings Chart

Analyst William Plovanic works at CANACCORD with a stock forecast success ratio of 54.88% fulfilled within 100.95 days on average.

William Plovanic’s has documented 368 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NVRO, Nevro Corp at 08-May-2024.

Wall Street Analyst William Plovanic

Analyst best performing recommendations are on CVRX (CVRX).
The best stock recommendation documented was for CVRX (CVRX) at 12/21/2023. The price target of $30 was fulfilled within 5 days with a profit of $4.67 (18.44%) receiving and performance score of 36.87.

Average potential price target upside

AFIB Acutus Medical  ANGO AngioDynamics ATRC AtriCure EW Edwards Lifesciences Corp IRT Independence Realty Trust MMSI Merit Medical Systems NARI Inari Medical  PEN Penumbra STIM Neuronetics SWAV Shockwave Medical BSX Boston Scientific Corp IRTC iRhythm Technologies LUNG Pulmonx Corp NUVA NuVasive NVRO Nevro Corp STAA STAAR Surgical Company SYK Stryker TMDX TransMedics Group VAPO Vapotherm CVRX CVRx YMAB Y mAbs Therapeutics

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$0.52 (236.36%)


9 months 18 days ago

5/8 (62.5%)

$0.1 (15.63%)




$1.28 (581.82%)

1 years 9 months 10 days ago

1/2 (50%)

$0.05 (3.45%)




$1.28 (581.82%)

1 years 11 months 2 days ago

1/5 (20%)

$0.96 (177.78%)




2 years 6 months 14 days ago

0/2 (0%)

$3.71 (16.84%)



$21.36 (1302.44%)


3 years 2 months 7 days ago

0/3 (0%)

$4.37 (22.18%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is William Plovanic is most bullish on?

Potential upside of $90.34 has been obtained for PEN (PENUMBRA)

Which stock is William Plovanic is most reserved on?

Potential downside of $0.85 has been obtained for SWAV (SHOCKWAVE MEDICAL)

What Year was the first public recommendation made by William Plovanic?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?